BioSpace News Archive

PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical-stage biotech company focusing on the development of fully human antibody therapeutics, announced today that Dr. Jin-San Yoo, Chairman and Chief Executive Officer of PharmAbcine is invited to participate in 40th Annual J.P. Morgan Healthcare Conference over January 10-13, 2022.

Curis, Inc., a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, announced the appointment of John A. Hohneker, M.D. to its Board of Directors.

Insmed Incorporated, a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, announced the granting of inducement awards to six new employees.

Seelos Therapeutics, Inc. (Nasdaq: SEEL), announced today that it has received an issued patent from the Japanese Patent Office (Japanese patent number 6968839, titled: STRUCTURE-BASED PEPTIDE INHIBITORS OF ALPHA-SYNUCLEIN AGGREGATION).

Goldfinch Bio today announced the appointment of Jeff W. Jacobs, Ph.D. as Chief Scientific Officer (CSO).

Novocure (NASDAQ: NVCR) today announced the 4th Annual AACR-Novocure Grants for Tumor Treating Fields Research Program.

Agilent Technologies Inc. (NYSE: A) has announced that the Agilent Cary 3500 UV-Vis Spectrophotometer is now compatible with the Agilent OpenLab software suite of products.

PharmaEssentia’s BESREMi ® (ropeginterferon alfa-2b-njft) Now Available for the Treatment of People With Polycythemia Vera in the United States.

sGuardant Health, Inc. announced it will present new data demonstrating the benefits of using the Guardant360® liquid biopsy test to help guide targeted therapy options for patients with advanced breast cancer at the 2021 San Antonio Breast Cancer Symposium on December 7-11.

Emmaus Life Sciences, Inc. (OTCQX: EMMA), today announced that data on Endari®, the company’s prescription L-glutamine oral powder for the treatment of sickle cell disease, has been accepted for a poster presentation at the 63rd American Society of Hematology (ASH) Annual Meeting and Exhibition.